
Sign up to save your podcasts
Or


Irritable bowel disease (IBD) often requires a personalized approach to treatment. So what does the current therapeutic drug monitoring landscape look like? Dr. Neil Nandi speaks with Dr. Andres Yarur, Associate Professor of Medicine at Cedars-Sinai in Los Angeles, about therapeutic drug monitoring for IBD.
By ReachMD4.7
1818 ratings
Irritable bowel disease (IBD) often requires a personalized approach to treatment. So what does the current therapeutic drug monitoring landscape look like? Dr. Neil Nandi speaks with Dr. Andres Yarur, Associate Professor of Medicine at Cedars-Sinai in Los Angeles, about therapeutic drug monitoring for IBD.

2,058 Listeners

695 Listeners

496 Listeners

69 Listeners

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

0 Listeners

0 Listeners

2,442 Listeners

3,332 Listeners

56,419 Listeners

1,153 Listeners

513 Listeners

252 Listeners

217 Listeners

13 Listeners

18 Listeners

33 Listeners